Guidant takeover won’t hit jobs
Industry sources do not expect either project to be scrapped in the event of a successful takeover, but cautioned: “In a takeover situation you can never be too sure what cost savings will be identified. The Irish operations of these companies are set for fair growth and it would be a major surprise if something was to go awry,” a source familiar with the deal said.
Johnson & Johnson, the world’s biggest maker of medical devices, is in talks to buy Guidant Corp for €18bn and may reach an agreement in the next few days.
